Sarepta Therapeutics, Inc.

Metabolic disease alliances have picked up as companies try to find a spot in the growing obesity market, and earlier this decade the COVID-19 pandemic drove a short-lived uptick in infectious disea

The US Food and Drug Administration was slated to transition Novavax’ s COVID-19 vaccine from emergency use authorization to full licensure on April 1, when Principal Deputy Commissioner Sara Brenner

News that US Food and Drug Administration Center for Biologics Evaluation and Research (CBER) director Peter Marks submitted his resignation, effective 5 April, late in the day on 28 March shook the b

With 48-week data from a Phase II open-label trial in Duchenne muscular dystrophy (DMD) showing an advancement in clinical benefit beyond what a 24-week readout showed last year, Wave Life Sciences sa